JPRN-UMIN000027305已完成未知
ow dose of lactulose for intestinal function. Randomized double-blind, placebo-controlled crossover study - Low dose of lactulose for intestinal function
Showa Women's University0 个研究点目标入组 60 人开始时间: 2017年5月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Subjects with severe hepatic, renal, heart, gastrointestinal, cerebrovascular, endocrine, metabolic or infection diseases. 2) Subjects with the history of gastrointestinal resection. 3) Subjects with gastrointestinal dysfunction such as irritable bowel syndrome or inflammatory bowel disease. 4) Subjects who use medicines or supplements that may influence feces frequency; e.g. antibiotics, probiotics, laxatives, antidiarrheals, fibers. 5) Subjects with milk allergy. 6) Subjects with lactose intolerance 7) Subjects who participate another study. 8) Subjects who are judged inappropriate for the study by the investigator or the physician.
研究者
相似试验
已完成
不适用
Minimum effective dose of lactulose for intestinal function. exploratory studyot applicableJPRN-UMIN000021219Showa Women's University30
已完成
不适用
Verification of intestinal action by intake of lactic acid bacteria (killed bacteria)Healthy adultsJPRN-UMIN000030350Shiba Palace Clinic60
已完成
不适用
Gastrointestinal tolerance of allulose in Korean adultsKCT0002216Kyungpook National University30
尚未招募
3 期
Role of oral lactoferrin in post refractive surgery dry eye.CTRI/2024/05/067780Dr R P Centre for Ophthalmic Sciences AIIMS
已完成
不适用
actulose effect in non alcoholic fatty liver diseaseon alcoholic fatty liver disease.Non alcoholic fatty liver diseaseIRCT2014010715879N3Vice chancellor for research, Tabriz university of medical sciences40